Kenya is among the countries set to benefit from enhanced screening and care for sickle cell anaemia.
This follows the announcement of a partnership between Novo Nordisk and the American Society of Haematology (ASH) to support the Consortium on Newborn Screening in Africa (CONSA) Community Health Worker (CHW) initiative.
According to data from the Ministry of Health, approximately 14,000 children are born with sickle cell disease in Kenya each year.
The genetic condition is particularly common in the Western, Nyanza, and Coastal regions.
